The KMT2B gene helps control when other genes are switched on during growth, especially in the brain. The protein made by this gene helps your cells place small chemical tags on DNA packaging, which guides normal development and movement control. If the KMT2B gene is not working properly, some people develop dystonia, a movement condition that causes twisting movements or unusual postures, often beginning in childhood. Some also have delays in speech, learning, or growth.
What is a gene?
Genes are stretches of DNA that provide cells with instructions for making molecules or for regulating processes in the body. Some genes hold the directions for producing proteins, the working parts of cells. Other genes are mainly involved in controlling when certain processes happen, where they take place, and how strongly they operate. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
KMT2BGene function
What if the gene works
The KMT2B gene helps control when other genes turn on or off by changing how DNA is packaged. This supports normal brain development, cell growth, and the smooth function of nerve cells.
Risk
What if the gene does not work
Variants in the KMT2B gene most often cause childhood onset dystonia, with involuntary twisting movements and abnormal postures. Some people also have developmental delay. Milder and more severe variants can affect when symptoms start and how much of the body is involved.
Treatment
What does that mean for your treatment
Pathogenic or loss-of-function variants in the KMT2B gene can make deep brain stimulation, usually targeting the globus pallidus, especially relevant because many people improve more than they do with standard dystonia medicines alone. Medicines such as anticholinergics, baclofen, or levodopa may still be used for symptom relief, but benefit often varies.
Conditions associated with KMT2B
Gene function
What if the gene works
Your cells need careful timing when they turn genes on and off. The KMT2B gene helps manage that timing by adding small chemical marks to DNA packaging proteins. This helps the body keep the right genes active as cells grow, specialize, and do their daily work.
The KMT2B gene places small chemical marks on histones (proteins that DNA wraps around). These marks help cells switch on selected genes at the right time.
By changing histones, this gene helps keep some stretches of DNA easier for the cell to read. That supports steady control of everyday gene activity.
During growth and development, the KMT2B gene helps cells follow the right instruction set for their future role. This helps tissues form in an orderly, coordinated way.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the KMT2B gene often reduce or disrupt a protein that helps control which other genes are switched on in cells. Some changes only partly lower this protein’s activity, while more disruptive variants can shorten it, make it unstable, or stop it from working. This range in KMT2B gene variant effects can influence how strongly cell control is altered, which may relate to earlier movement symptoms or a broader pattern of features in some people.
How variants are linked to conditions
Pathogenic variants in the KMT2B gene can cause KMT2B-related dystonia, a movement condition that often starts in childhood and may spread from the legs to other parts of the body. Some people also have developmental delay, learning difficulties, short stature, or mental health symptoms. If you are reading about KMT2B-related dystonia symptoms, it helps to know that the pattern and severity can vary a lot from one person to another.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found in the general population. Most do not have a direct effect on health and instead reflect normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For KMT2B, risk is mainly shaped by whether you carry a disease-causing change in the KMT2B gene. If a parent has that change, the chance for a child is higher, although some people develop it because the change happened for the first time in them. There is not enough evidence to say that lifestyle changes lower this genetic risk.
Inheritance of KMT2B variants
KMT2B-related dystonia is usually inherited in an autosomal dominant pattern, which means a child can inherit the condition if one parent carries a disease-causing variant in the KMT2B gene. In families where a parent has the variant, each child has a 50% chance of inheriting it. Many people learning how KMT2B variants are inherited also find that some cases happen for the first time through a new variant, meaning it was not passed down from either parent. Both males and females can inherit and pass on this kind of KMT2B gene variant.
What does my KMT2B result mean for my family?
KMT2B-related dystonia usually follows a dominant inheritance pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same gene change and may want to discuss testing. In many families, an affected parent can pass it on to a child. Some cases happen for the first time in one person, so a parent may not have the change.
Genetic information
Genetic testing
How you find out about variants
KMT2B genetic testing to find out about variants usually uses a blood or saliva sample. A lab reads the KMT2B gene, often with sequencing and copy number analysis, to look for changes such as small variants or missing or extra pieces that may help explain symptoms.
When should I consider getting a genetic test?
Testing for changes in the KMT2B gene may be worth considering if someone, especially a child or teen, develops unexplained twisting movements, abnormal postures, trouble walking, or speech changes that started early in life. It can also help when there is a family history of similar movement problems or learning and developmental differences.
A genetic result is only one part of your health story
Genetic results can provide meaningful insight, although what they tell you varies depending on the condition and the specific type of variant. How the body works over time is also shaped by many other factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information adds context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment, yet one may get the intended benefit while the other may notice less effect or more side effects. Part of the reason is that inherited differences can change how the body breaks down, transports, or responds to a drug. This kind of variation is common and is one reason medication response is not the same for everyone.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences can shape a person’s response to medications. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how the body handles a drug or how strong its effects are. This information can support more informed, more personalized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the KMT2B gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen, so talk with your doctor about any questions on treatment, side effects, or new symptoms, especially before starting or changing a medicine.
History
In recent decades, awareness of the KMT2B gene’s role has grown. Researchers first identified KMT2B during the wave of human gene mapping in the 1990s, and its place within a larger gene family became clearer as DNA sequencing improved. A major milestone came in 2016, when pathogenic variants in the KMT2B gene were firmly linked to a form of early-onset dystonia, helping explain why some children developed worsening movement problems without a clear cause. From these first observations, research expanded steadily. Since then, broader genetic testing has shown that KMT2B-related conditions can look different from person to person, which has refined diagnosis and care.